Immune complexome analysis of serum and its application in screening for immune complex antigens in rheumatoid arthritis

Clinical Chemistry

Volumn 57, Issue 6, 2011, Pages 905-909

  Ohyama, Kaname ^a   Ueki, Yukitaka ^b   Kawakami, Atsushi ^a   Kishikawa, Naoya ^a   Tamai, Mami ^a   Osaki, Makoto ^a   Kamihira, Shimeru ^a   Nakashima, Kenichiro ^a   Kuroda, Naotaka ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b SASEBO CHUO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B100; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; AUTOANTIGEN; CLUSTERIN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT FACTOR H; FIBRONECTIN; GALECTIN 3; HIGH MOLECULAR WEIGHT KININOGEN; IMMUNE COMPLEX ANTIGEN; PLASMINOGEN; PROTHROMBIN; RHEUMATOID FACTOR; THROMBOCYTE FACTOR 4; THROMBOSPONDIN 1; TRYPSIN; UNCLASSIFIED DRUG; VITRONECTIN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; FRAGMENTATION REACTION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; OSTEOARTHRITIS; OUTCOME ASSESSMENT; RHEUMATOID ARTHRITIS; SERUM; TANDEM MASS SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGEN-ANTIBODY COMPLEX; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; NANOTECHNOLOGY; PLATELET FACTOR 4; PROTEOME; TANDEM MASS SPECTROMETRY; THROMBOSPONDIN 1;

ANIMALIA;

EID: 79957673692     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.157776     Document Type: Article

References (16)

1. Robinson WH, DiGennaro C, Huber W, Haas BB, Kamachi M, Dean EJ, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002;8:295-301. (Pubitemid 34250109)
2. Zubler RH, Nydegger U, Perrin LH, Fehr K, McCormick J, Lambert PH, Miescher PA. Circulating and intra-articular immune complex in patients with rheumatoid arthritis. Correlation of 125l-C1q binding activity with clinical and biological features of the disease. J Clin Invest 1976;57:1308-19.
3. Van Steendam K, Tilleman K, De Ceuleneer M, De Keyser F, Elewaut D, Deforvce D. Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins. Arthritis Res Ther 2010;12:R132.
4. Monach PA, Hueber W, Kessler B, Tomooka BH, BenBarak M, Simmons BP, et al. A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis. Proc Natl Acad Sci U S A 2009;106:15867-72.
5. Zhao X, Okeke NL, Sharpe O, Batliwalla FM, Lee AT, Ho PP, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther 2008;10:R94.
6. Cooke TD, Hurd ER, Jasin HE, Bienenstock J, Ziff M. Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum 1975;18:541-55.
7. Masson-Bessiere C, Sebbag M, Durieux JJ, Nogueira L, Vincent C, Gribal-Neuhauser E, et al. In the rheumatoid pannus, anti-fillaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000;119:544-52.
8. De Rycke, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, et al. Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extraarticular manifestations. Ann Rheum Dis 2004;63:1587-93.
9. Dorner T, Egerer K, Feist E, Buurmester G. Rheumatoid factor revisited. Curr Opinon Rheumatol 2004;16:246-53. (Pubitemid 38530493)
10. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63. (Pubitemid 30368225)
11. Gotis-Graham I, Hogg PJ, McNeil HP. Significant correlation between thrombospondin 1 and serine proteinase expression in rheumatoid synovium. Arthritis Rheum 1997;40:1780-7. (Pubitemid 27452527)
12. Rico M, Manns JM, Driban JB, Uknis AB, Kunapuli SP, Dela Cadena RA. Thrombospondin-1 and transforming growth factor beta are proinflammatory molecules in rheumatoid arthritis. Transl Res 2008;152:95-8.
13. Rico MC, Castaneda JL, Manns JM, Uknis AB, Sainz IM, Safadi FF, et al. Amelioration of inflammation, angiogenesis and CTGF expression in an arthritis model by a TSP1-derived peptide treatment. J Cell Physiol 2007;211:504-12. (Pubitemid 46580104)
14. Rico MC, Rough JJ, Del Carpio-Cano FE, Kunapuli SP, Dela Cadena RA. The axis of thromobospondin-1, transforming growth factor beta and connective tissue growth factor: an emerging therapeutic target in rheumatoid arthritis. Curr Vasc Rhumatol 2010;8:338-43.
15. Xiao Z, Visentin GP, Dayananda KM, Neelamegham S. Immune complexes formed following the binding of anti-platelet 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion. Blood 2008;112:1091-100.
16. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 1990;247:77-9.